These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3882856)

  • 41. Type 6 and 19 pneumococcal polysaccharides coupled to erythrocytes elicit pneumococcal cell wall-specific primary IgM responses and capsular polysaccharide-specific secondary IgG responses.
    Milligan GN; Fairchild RL; Sterner KE; Braley-Mullen H
    Eur J Immunol; 1990 Mar; 20(3):595-603. PubMed ID: 2318251
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conjugation of β-glucan markedly increase the immunogencity of meningococcal group Y polysaccharide conjugate vaccine.
    Qiao W; Ji S; Zhao Y; Hu T
    Vaccine; 2015 Apr; 33(17):2066-72. PubMed ID: 25728319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and immunogenicity of Haemophilus influenzae type B polysaccharide-diphtheria toxoid conjugate vaccine in adults.
    Lepow ML; Samuelson JS; Gordon LK
    J Infect Dis; 1984 Sep; 150(3):402-6. PubMed ID: 6332863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of antibodies against outer-membrane proteins in murine resistance to infection with encapsulated Klebsiella pneumoniae.
    Serushago BA; Mitsuyama M; Handa T; Koga T; Nomoto K
    J Gen Microbiol; 1989 Aug; 135(8):2259-68. PubMed ID: 2699330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenic properties of Klebsiella pneumoniae type 2 capsular polysaccharide.
    Robert A; Jouin H; Fournier JM
    Infect Immun; 1986 Nov; 54(2):365-70. PubMed ID: 3095240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of the humoral immune response to Klebsiella species in inflammatory bowel disease and ankylosing spondylitis.
    Tiwana H; Walmsley RS; Wilson C; Yiannakou JY; Ciclitira PJ; Wakefield AJ; Ebringer A
    Br J Rheumatol; 1998 May; 37(5):525-31. PubMed ID: 9651080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of pneumococcal bacteremia by immunization with type 6 pneumococcal capsular polysaccharide vaccine in splenectomized rats.
    Iinuma H; Okinaga K
    J Infect Dis; 1989 Jul; 160(1):66-75. PubMed ID: 2732517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progress towards the development of Klebsiella vaccines.
    Choi M; Tennant SM; Simon R; Cross AS
    Expert Rev Vaccines; 2019 Jul; 18(7):681-691. PubMed ID: 31250679
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunoprotective potential of polysaccharide-tetanus toxoid conjugate in Klebsiella pneumoniae induced lobar pneumonia in rats.
    Chhibber S; Rani M; Vanashree Y
    Indian J Exp Biol; 2005 Jan; 43(1):40-5. PubMed ID: 15691064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of capsular polysaccharide of Klebsiella pneumoniae on Host resistance to bacterial infections. II. Effects on peritoneal leukocytes of normal mice and mice infected with virulent Salmonella enteritidis.
    Kato N; Kato O; Nakashima I
    Jpn J Microbiol; 1976 Oct; 20(5):415-23. PubMed ID: 792533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunochemical properties of oligosaccharide-protein conjugates with Klebsiella-K2-specificity. II. Protective capacity of the conjugates and anti-conjugate antibodies against infection with Klebsiella pneumoniae 01:K2 in mice.
    Geyer H; Schlecht S; Himmelspach K
    Med Microbiol Immunol; 1982; 171(3):135-43. PubMed ID: 6186899
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody responses to pneumococcal capsular polysaccharide: what is being measured?
    Goldblatt D; Jadresic LP; Levinsky RJ; Turner MW
    Immunodeficiency; 1993; 4(1-4):47-50. PubMed ID: 8167732
    [No Abstract]   [Full Text] [Related]  

  • 53. [An immunoenzymatic test for IgG antibody levels against 10 serotypes of Streptococcus pneumoniae].
    Leal-Esteban LC; Rojas JL; Jaimes AL; Montoya JD; Montoya NE; Leiva L; Trujillo-Vargas CM
    Biomedica; 2012; 32(1):92-102. PubMed ID: 23235791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of Klebsiella pneumoniae Serotypes K1 and K2.
    Siu LK; Tsai YK; Lin JC; Chen TL; Fung CP; Chang FY
    J Clin Microbiol; 2016 Dec; 54(12):3018-3021. PubMed ID: 27707941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccination against Klebsiella aerogenes.
    Roe EA; Jones RJ
    J Hyg (Lond); 1984 Oct; 93(2):355-63. PubMed ID: 6389699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conjugate vaccines against group B Streptococcus types IV and VII.
    Paoletti LC; Kasper DL
    J Infect Dis; 2002 Jul; 186(1):123-6. PubMed ID: 12089673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunochemical relations between pneumococcal group 19 and Klebsiella capsular polysaccharides.
    Lee CJ; Koizumi K
    J Immunol; 1981 Oct; 127(4):1619-23. PubMed ID: 6792279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of intravenous immune globulins against Klebsiella.
    Cryz SJ; Cross AS; Fürer E; Chariatte N; Sadoff JC; Germanier R
    J Lab Clin Med; 1986 Sep; 108(3):182-9. PubMed ID: 3746094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunoprotective activity of capsular polysaccharide in Klebsiella pneumoniae ribosomal preparations does not involve ribonucleic acid.
    Riottot MM; Fournier JM
    Infect Immun; 1981 Oct; 34(1):126-30. PubMed ID: 6170582
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune responses to the capsular polysaccharide of Mycoplasma dispar in calves and mice.
    Bansal P; Adegboye DS; Rosenbusch RF
    Comp Immunol Microbiol Infect Dis; 1995 Sep; 18(4):259-68. PubMed ID: 8549115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.